QualityStocksNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) CEO Discusses GelrinC(R), U.S. Pivotal Study and European Commercialization on BioMedWire Podcast
Regentis Biomaterials (NYSE American: RGNT) Executive Chairman and CEO Dr. Ehud Geller joined the latest episode of The BioMedWire Podcast…